Pediatric Proteus syndrome: A rare case report with focus on clinical management and long-term outcomes
DOI:
https://doi.org/10.3889/aph.2026.6574Keywords:
Proteus syndrome, AKT1 mutation, overgrowth disorder, vascular anomalies, multidisciplinary managementAbstract
Proteus syndrome (PS) is a rare mosaic genetic disorder caused by а somatic mutations in the AKT1 gene, resulting in asymmetric overgrowth of skin, skeleton, soft tissues, and internal organs. Progressive tissue expansion and vascular anomalies increase the risk of functional impairment and thromboembolic complications. Aim of the paper was to describe the clinical presentation, diagnostic evaluation, and management of a pediatric patient with PS, highlighting the role of multidisciplinary care. Case report: A 4-year-old girl presented with right upper limb overgrowth and a soft-tissue mass in the pectoral region. Diagnosis was confirmed via clinical assessment, radiologic imaging, and genetic testing for AKT1 mutation. Surgical excision of hypertrophic tissue was performed, and histopathology confirmed a benign lipomatous lesion. A two-year follow-up included monitoring of functional outcomes and disease recurrence. Postoperative recovery was uneventful, with primary wound healing. Progressive hypertrophy necessitated a second surgical intervention. Multidisciplinary follow-up facilitated timely management of emerging complications without major adverse events. Conclusion: PS requires early diagnosis and individualized, multidisciplinary management. Surgical interventions improve function, but long-term surveillance is essential due to the progressive nature of the disorder.
Downloads
References
Updated classification of vascular anomalies: A living document from the International Society for the Study of Vascular Anomalies Classification Group. Journal of Vascular Anomalies. 2025;6(2):e113. doi: 10.1097/JOVA.0000000000000113.
Rostagni OM, Early CLR, Hodges MB, Obasohan J, Sapp JC, Livinski AA, et al. Tumour spectrum in AKT1‑related Proteus syndrome: a systematic review of clinical reports and series. J Med Genet. 2025;62(2):74‑81. doi:10.1136/jmg‑2024‑110173.
Yin Y, Sun L, Tian W. Progress in diagnosis and treatment of Proteus syndrome. Journal of Rare Diseases. 2023;2(4):626–632. doi:10.12376/j.issn.20970501.2023.04.020.
Cohen MM Jr. Historical perspectives and case reports of Proteus syndrome: re-evaluation of Elephant Man’s condition. Am J Med Genet C. 2021;187(1):45–52. doi:10.1002/ajmg.c.31823.
Biesecker LG. The Elephant Man and Proteus syndrome: modern clinical insights. Clin Genet. 2022;101(3):233–241. doi:10.1111/cge.14129.
Khaladkar SM, Jhala NA, Krishnani KS, Durgi EC. Proteus Syndrome: A rare congenital disorder. Cureus. 2024;16(5):e60072. doi:10.7759/cureus.60072.
Abell K, Tolusso L, Smith N, Hopkin R, Vawter‑Lee M, Habli M, et al. Prenatal diagnosis of Proteus syndrome: Diagnosis of an AKT1 mutation from amniocytes. Birth Defects Res. 2020. doi:10.1002/bdr2.1801
Eng W, Iacobas I, Perkins J, et al. Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA‑related overgrowth spectrum or Proteus syndrome. Orphanet J Rare Dis. 2025;20:375. doi:10.1186/s13023‑025‑03831‑z.
VanderPlas M, Ling Y, Chen J, et al. Long-term clinical outcomes and surveillance strategies in Proteus syndrome: a multicenter cohort study. Orphanet Journal of Rare Diseases. 2021;16:233. doi:10.1186/s13023-021-01900-5.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Roza Sokolova, Lazo Jovceski, Shaban Memeti

This work is licensed under a Creative Commons Attribution 4.0 International License.
All wrights are reserved.


